Related Tags >> breast cancer Abraxane Cancer Drugs biopharmaceutical company

Paclitaxel News

Most Popular Paclitaxel Story

ALSO NOTED: Phyton cuts staff; Alzheimer's: A new indication for Enbrel?; and much more...

January 10, 2008 — 6:59am ET

> According to research released today, the anti-rheumatoid arthritis med Enbrel has shown an amazing ability to rehabilitate Alzheimer's patients. Read more...

Paclitaxel Press Releases

Synta Announces Publication of Results Showing Ganetespib Synergizes with Taxanes in Multiple Non-small Cell Lung Cancer M
Merrimack Pharmaceuticals Initiates Enrollment in a Neoadjuvant Phase 2 Study of MM-121 with Paclitaxel in HER2-negative Breast
Puma Biotechnology Announces Licensing Agreement with Pfizer for the Development and Commercialization of Neratinib, an Investig
Sunshine Biopharma's Adva-27a is 16-times more effective at killing multidrug resistant breast cancer cells
Precision Therapeutics Presents Clinical Study Emphasizing the Role of ChemoFx® in Directing Chemotherapy in Gynecological Cance

Latest Headlines

Cephalon paying $10M in cancer tech deal
March 31, 2008
Avanti launches bionano company
March 28, 2008
ALSO NOTED: Phyton cuts staff; Alzheimer's: A new indication for Enbrel?; and much more...
January 10, 2008
Avastin re-submitted to FDA
August 24, 2007
Press Release: Phase III Trial of Nexavar Does Not Meet Primary Endpoint
December 3, 2006
SPOTLIGHT: Synta gets fast track for cancer therapy
November 14, 2006
Press Release: Synta Pharmaceuticals gets FDA Fast Track Designation for STA-4783
November 14, 2006
Editor's Corner
October 16, 2006
SPOTLIGHT: Synta trial hits endpoint
September 14, 2006
ALSO NOTED: Barr raises bid on Pliva; Synta touts new data; regulators question Factive rashes;and much more...
September 10, 2006
ALSO NOTED: FDA wants new NeoPharm trial; GSK may bid for Pfizer's OTC unit; and much more...
February 8, 2006
ALSO NOTED: FDA requires electronic drug labeling; Niccotine vaccine on the horizon; Cancer drug could fight scleroderma; and m
November 2, 2005
ALSO NOTED: FDA wants more safety data on Pargluva; Genentech disappointed by Tarceva, Avastin combo; Schering takes stake in S
October 17, 2005
ALSO NOTED: Altana acquires dermatology business; BioDelivery prices shares; NeoPharm touts new version of cancer drug; and muc
September 29, 2005
Sanofi-Aventis touts survival data in Taxotere study
August 18, 2005
Sonus shares surge as FDA approves Phase III design
July 7, 2005

Paid Research Reports

More Research Reports >>